Overexpression of SLC7A11: a novel oncogene and an indicator of unfavorable prognosis for liver carcinoma

SLC7A11 Overexpression in Glioblastoma Is Associated with Increased Cancer Stem Cell-Like Properties

(2017) Monika D. Polewski et al.   STEM CELLS AND DEVELOPMENT

CD147 as a Novel Prognostic Biomarker for Hepatocellular Carcinoma: A Meta-Analysis

(2017) Fei Peng et al.   Biomed Research International

MiR-375/SLC7A11 axis regulates oral squamous cell carcinoma proliferation and invasion

(2017) Yadong Wu et al.   Cancer Medicine

Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer

(2016) Jong-Lyel Roh et al.   CANCER LETTERS

Ferroptosis: process and function

(2016) Y Xie et al.   CELL DEATH AND DIFFERENTIATION

Dietary trace element intake and liver cancer risk: Results from two population-based cohorts in China

(2016) Xiao Ma et al.   INTERNATIONAL JOURNAL OF CANCER

Increased Expression of System x c − in Glioblastoma Confers an Altered Metabolic State and Temozolomide Resistance

(2016) Monika D. Polewski et al.   MOLECULAR CANCER RESEARCH

Non-infective occupational risk factors for hepatocellular carcinoma: A review

(2016) Caterina Ledda et al.   Molecular Medicine Reports

Exposure to inorganic arsenic can lead to gut microbe perturbations and hepatocellular carcinoma

(2016) Jonathan Choiniere et al.   Acta Pharmaceutica Sinica B

Histopathology of hepatocellular carcinoma

(2016) Manuel Schlageter et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Senescence marker protein 30 (SMP30) serves as a potential prognostic indicator in hepatocellular carcinoma

(2016) Zhijing Mo et al.   Scientific Reports

Xc− inhibitor sulfasalazine sensitizes colorectal cancer to cisplatin by a GSH-dependent mechanism

(2015) Ming-zhe Ma et al.   CANCER LETTERS

Ferroptosis as a p53-mediated activity during tumour suppression

(2015) Le Jiang et al.   NATURE

Excitotoxic SLC7A11 Expression Is a Marker of Poor Glioblastoma Survival and a Potential Therapeutic Target

(2015) Ray R. Zhang et al.   NEUROSURGERY

Drug repurposing: sulfasalazine sensitizes gliomas to gamma knife radiosurgery by blocking cystine uptake through system Xc−, leading to glutathione depletion

(2015) L Sleire et al.   ONCOGENE

Prognostic significance of amino-acid transporter expression (LAT1, ASCT2 and xCT) in surgically resected tongue cancer

(2014) M Toyoda et al.   BRITISH JOURNAL OF CANCER

Reduced Expression of miRNA-27a Modulates Cisplatin Resistance in Bladder Cancer by Targeting the Cystine/Glutamate Exchanger SLC7A11

(2014) R. M. Drayton et al.   CLINICAL CANCER RESEARCH

Functional role of CD44v-xCT system in the development of spasmolytic polypeptide-expressing metaplasia

(2013) Takeyuki Wada et al.   CANCER SCIENCE

Cystine/glutamic acid transporter is a novel marker for predicting poor survival in patients with hepatocellular carcinoma

(2012) HIROKI KINOSHITA et al.   ONCOLOGY REPORTS

Causes of and Prevention Strategies for Hepatocellular Carcinoma

(2012) Giuseppe Cabibbo et al.   SEMINARS IN ONCOLOGY

Disruption of xCT inhibits cell growth via the ROS/autophagy pathway in hepatocellular carcinoma

(2011) Weijie Guo et al.   CANCER LETTERS